|
Neotrofin for treatment of chemotherapy-induced peripheral neuropathy Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Neotrofin for treatment of chemotherapy-induced peripheral neuropathy conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Neotrofin for treatment of chemotherapy-induced peripheral neuropathy Clinical research trials and Neotrofin for treatment of chemotherapy-induced peripheral neuropathy health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Neotrofin for treatment of chemotherapy-induced peripheral neuropathy. Neotrofin for treatment of chemotherapy-induced peripheral neuropathy Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Neotrofin for treatment of chemotherapy-induced peripheral neuropathy clinical trial. Participants oftentimes recieve the most expert healthcare available for their Neotrofin for treatment of chemotherapy-induced peripheral neuropathy condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "N" Clinical Trials Conditions > Neotrofin for treatment of chemotherapy-induced peripheral neuropathy  Neotrofin for treatment of chemotherapy-induced peripheral neuropathy
Neotrofin for treatment of chemotherapy-induced peripheral neuropathy
For Condition: Peripheral Nervous System Diseases,Chemotherapy-Induced Peripheral Neuropathy
Status: Recruiting
Sponsor(s): NeoTherapeutics ,
Synopsis: This study will assess the safety and efficacy of Neotrofin in treating the peripheral neuropathy that results from chemotherapy for cancer.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/80 Years
Genders: Both
Protocol Entry Criteria: - Patient must have diagnosis of cancer and be receiving or have received chemotherapy that has resulted in sensory or motor neuropathy. - Sensory or motor neuropathy must be >/= grade 2 per Common Toxicity Criteria at baseline. - In patients diagnosed with multiple myeloma, grade 1 sensory or motor neuropathy is acceptable. - Patient must have normal hematological cell counts. - Patient must have a life expectancy of >/= 3 months.
Total Enrollment: 50
Location and Contact Information:
NYU Medical Center *Recruiting*
New York City, New York, 10016
United States
Recruiting Franco Muggia
Providence Holy Cross Medical Center *Recruiting*
Mission Hills, California, 91345
United States
Recruiting Shamel Sanani
The Sarah Cannon Cancer Center *Recruiting*
Nashville, Tennessee, 37203
United States
Recruiting John Hainsworth
Providence St. Joseph Medical Center *Recruiting*
Burbank, California, 91505
United States
Recruiting Raul Mena
Alta Bates Comprehensive Cancer Center *Recruiting*
Berkeley, California, 94704
United States
Recruiting David Irwin
Washington University School of Medicine *Recruiting*
St. Louis, Missouri, 63110
United States
Recruiting Benjamin Tan
Additional Information:
Study ID Numbers: 082-2001-005;
Study Start Date: January 2002
Record last reviewed: July 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00041795
Other Chemotherapy-Induced Peripheral Neuropathy Studies:
1. Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
2. HIV-Related Peripheral Neuropathy
3. Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
4. Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
5. Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy
Related Studies:
Other Chemotherapy-Induced Peripheral Neuropathy Clinical Trials
Other Tennessee Clinical Trials
Other Nashville Clinical Trials
Neotrofin for treatment of chemotherapy-induced peripheral neuropathy
|
|
|
|
|
|
|
|
